Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 05, 2025 Filed Nov 7, 2025 17:14 UTC |
Breitfeld Philip P.Director
|
GrantOption to purchase Common Stock · Derivative | 13,790 | $6.80 Strike: $6.80 | $93,772.00 |
DisclosureSEC source: 0001628280-25-050522 · wk-form4_1762535675.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,790 Underlying: Common Stock · 13,790 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 16:57 UTC |
SIDRANSKY DAVIDDirector
|
GrantOption to purchase Common Stock · Derivative | 21,216 | $6.80 Strike: $6.80 | $144,268.80 |
DisclosureSEC source: 0001628280-25-050514 · wk-form4_1762534641.xml · derivative · entry 1 SIDRANSKY DAVID · CIK 0001277161 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,216 Underlying: Common Stock · 21,216 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 16:18 UTC |
Mendelson Daniel NewmanDirector
|
GrantOption to purchase Common Stock · Derivative | 13,790 | $6.80 Strike: $6.80 | $93,772.00 |
DisclosureSEC source: 0001628280-25-050491 · wk-form4_1762532316.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,790 Underlying: Common Stock · 13,790 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 16:00 UTC |
TOBIN SCOTT RDirector · 10% owner
|
GrantOption to purchase Common Stock · Derivative | 25,460 | $6.80 Strike: $6.80 | $173,128.00 |
DisclosureSEC source: 0001628280-25-050481 · wk-form4_1762531198.xml · derivative · entry 1 TOBIN SCOTT R · CIK 0001199926 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,460 Underlying: Common Stock · 25,460 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 15:26 UTC |
ACKERMAN JOELDirector
|
GrantOption to purchase Common Stock · Derivative | 21,216 | $6.80 Strike: $6.80 | $144,268.80 |
DisclosureSEC source: 0001628280-25-050467 · wk-form4_1762529216.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,216 Underlying: Common Stock · 21,216 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| October 30, 2025 Filed Nov 6, 2025 16:19 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionOption to purchase Common Stock · Derivative | 94,405 | $2.10 Strike: $2.10 | $198,250.50 |
DisclosureSEC source: 0001628280-25-049954 · wk-form4_1762445975.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,405 shares Expires 2025-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 70,804 options were immediately exercisable on grant date of July 19, 2016, with the remaining options vesting and available to exercise on October 31, 2016. Read SEC document |
| October 30, 2025 Filed Nov 6, 2025 16:19 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionCommon Stock | 94,405 | $2.10 | $198,250.50 |
DisclosureSEC source: 0001628280-25-049954 · wk-form4_1762445975.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,056,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2025 Filed Jan 30, 2026 20:55 UTC |
Brainin Robert LawrenceDirector · CEO
|
GrantOption to purchase Common Stock · Derivative | 100,000 | $7.80 Strike: $7.80 | $780,000.00 |
DisclosureSEC source: 0001628280-26-004381 · wk-form4_1769806532.xml · derivative · entry 6 Brainin Robert Lawrence · CIK 0002088015 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774,163 Underlying: Common Stock · 100,000 shares Expires 2035-07-16 F6 · derivative.exercise_date: The options will vest and be exercisable on the first date on which the average closing price (rounded to the nearest penny) of the Company's listed stock for the then previous forty five (45) calendar days is equal to or greater than the $24.00 Strike Price. Read SEC document |
| July 16, 2025 Filed Jan 30, 2026 20:55 UTC |
Brainin Robert LawrenceDirector · CEO
|
GrantOption to purchase Common Stock · Derivative | 100,000 | $7.80 Strike: $7.80 | $780,000.00 |
DisclosureSEC source: 0001628280-26-004381 · wk-form4_1769806532.xml · derivative · entry 5 Brainin Robert Lawrence · CIK 0002088015 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 674,163 Underlying: Common Stock · 100,000 shares Expires 2035-07-16 F5 · derivative.exercise_date: The options will vest and be exercisable on the first date on which the average closing price (rounded to the nearest penny) of the Company's listed stock for the then previous forty five (45) calendar days is equal to or greater than the $16.00 Strike Price. Read SEC document |
| July 16, 2025 Filed Jan 30, 2026 20:55 UTC |
Brainin Robert LawrenceDirector · CEO
|
GrantOption to purchase Common Stock · Derivative | 150,000 | $7.80 Strike: $7.80 | $1,170,000.00 |
DisclosureSEC source: 0001628280-26-004381 · wk-form4_1769806532.xml · derivative · entry 4 Brainin Robert Lawrence · CIK 0002088015 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,163 Underlying: Common Stock · 150,000 shares Expires 2035-07-16 F4 · derivative.exercise_date: The options will vest and be exercisable if (i) the Company achieves EBITDA of $35 million over any consecutive four quarter period (based on the Company's fiscal year) or (ii) when $30 million of the Company's data revenue is recognized over any consecutive four quarter period (based on the Company's fiscal year). Read SEC document |
| July 16, 2025 Filed Jan 30, 2026 20:55 UTC |
Brainin Robert LawrenceDirector · CEO
|
GrantOption to purchase Common Stock · Derivative | 62,500 | $7.80 Strike: $7.80 | $487,500.00 |
DisclosureSEC source: 0001628280-26-004381 · wk-form4_1769806532.xml · derivative · entry 3 Brainin Robert Lawrence · CIK 0002088015 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,163 Underlying: Common Stock · 62,500 shares Expires 2035-07-16 F3 · derivative.exercise_date: The options will vest and be exercisable when $15 million of the Company's data revenue is recognized over any consecutive four quarter period (based on the Company's fiscal year). Read SEC document |
| July 16, 2025 Filed Jan 30, 2026 20:55 UTC |
Brainin Robert LawrenceDirector · CEO
|
GrantOption to purchase Common Stock · Derivative | 62,500 | $7.80 Strike: $7.80 | $487,500.00 |
DisclosureSEC source: 0001628280-26-004381 · wk-form4_1769806532.xml · derivative · entry 2 Brainin Robert Lawrence · CIK 0002088015 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,663 Underlying: Common Stock · 62,500 shares Expires 2035-07-16 F2 · derivative.exercise_date: The options will vest and be exercisable if the Company achieves EBITDA of $25 million over any consecutive four quarter period (based on the Company's fiscal year). Read SEC document |
| July 16, 2025 Filed Jan 30, 2026 20:55 UTC |
Brainin Robert LawrenceDirector · CEO
|
GrantOption to purchase Common Stock · Derivative | 225,000 | $7.80 Strike: $7.80 | $1,755,000.00 |
DisclosureSEC source: 0001628280-26-004381 · wk-form4_1769806532.xml · derivative · entry 1 Brainin Robert Lawrence · CIK 0002088015 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,163 Underlying: Common Stock · 225,000 shares Expires 2035-07-16 F1 · derivative.exercise_date: The options vest and become exercisable as follows: 25% will vest on the one-year anniversary of the grant date on July 16, 2026; the balance will vest ratably at a rate of 1/36th each month thereafter. Read SEC document |
| March 25, 2025 Filed Apr 2, 2025 20:20 UTC |
Breitfeld Philip P.Director
|
OtherCommon Stock | 4,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016197 · wk-form4_1743625230.xml · nonDerivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,717 F1 · kind: Shares were transferred to a donor-advised charitable trust fund; upon receipt of the shares, the fund sold the shares. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 17:14 UTC |
Breitfeld Philip P.Director
|
GrantOption to purchase Common Stock · Derivative | 18,715 | $4.64 Strike: $4.64 | $86,837.60 |
DisclosureSEC source: 0001628280-24-048217 · wk-form4_1731950043.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,715 Underlying: Common Stock · 18,715 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 16:18 UTC |
Mendelson Daniel NewmanDirector
|
GrantOption to purchase Common Stock · Derivative | 21,590 | $4.64 Strike: $4.64 | $100,177.60 |
DisclosureSEC source: 0001628280-24-048205 · wk-form4_1731946727.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,590 Underlying: Common Stock · 21,590 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 16:47 UTC |
SIDRANSKY DAVIDDirector
|
GrantOption to purchase Common Stock · Derivative | 21,880 | $4.64 Strike: $4.64 | $101,523.20 |
DisclosureSEC source: 0001628280-24-048211 · wk-form4_1731948454.xml · derivative · entry 1 SIDRANSKY DAVID · CIK 0001277161 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,880 Underlying: Common Stock · 21,880 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 16:09 UTC |
TOBIN SCOTT RDirector · 10% owner
|
GrantOption to purchase Common Stock · Derivative | 34,550 | $4.64 Strike: $4.64 | $160,312.00 |
DisclosureSEC source: 0001628280-24-048196 · wk-form4_1731946138.xml · derivative · entry 1 TOBIN SCOTT R · CIK 0001199926 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,550 Underlying: Common Stock · 34,550 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 15:59 UTC |
ACKERMAN JOELDirector
|
GrantOption to purchase Common Stock · Derivative | 43,190 | $4.64 Strike: $4.64 | $200,401.60 |
DisclosureSEC source: 0001628280-24-048193 · wk-form4_1731945585.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,190 Underlying: Common Stock · 43,190 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| November 12, 2024 Filed Jan 30, 2026 17:15 UTC |
Brainin Robert LawrenceDirector
|
GrantOption to purchase Common Stock · Derivative | 23,030 | $4.64 Strike: $4.64 | $106,859.20 |
DisclosureSEC source: 0001628280-26-004342 · wk-form4_1769793351.xml · derivative · entry 4 Brainin Robert Lawrence · CIK 0002088015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,163 Underlying: Common Stock · 23,030 shares Expires 2034-11-12 F4 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionOption to purchase Common Stock · Derivative | 16,667 | $5.43 Strike: $5.43 | $90,501.81 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,667 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 4,167 options were immediately exercisable on November 4, 2019 with the remaining options vesting and available to exercise on February 4, 2020, May 4, 2020 and August 4, 2020. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionOption to purchase Common Stock · Derivative | 88,470 | $2.10 Strike: $2.10 | $185,787.00 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 88,470 shares Expires 2024-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options were immediately exercisable upon grant on July 19, 2016. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionCommon Stock | 16,667 | $5.43 | $90,501.81 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 962,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionCommon Stock | 88,470 | $2.10 | $185,787.00 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 945,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 16:45 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 1,000 | $6.50 | $6,500.00 |
DisclosureSEC source: 0001628280-24-001334 · wk-form4_1705423535.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,625 Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 17:47 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 2,000 | $6.27 | $12,540.00 |
DisclosureSEC source: 0001628280-24-001231 · wk-form4_1705081618.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,625 Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 15:57 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 2,944 | $6.31 | $18,576.64 |
DisclosureSEC source: 0001628280-24-001118 · wk-form4_1704988646.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,625 Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 13:57 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 3,000 | $6.25 | $18,750.00 |
DisclosureSEC source: 0001628280-24-001002 · wk-form4_1704895046.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,681 Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 14:08 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 1,000 | $6.15 | $6,150.00 |
DisclosureSEC source: 0001628280-24-000896 · wk-form4_1704809286.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,681 Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 20:11 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 2,000 | $6.09 | $12,180.00 |
DisclosureSEC source: 0001628280-24-000825 · wk-form4_1704744709.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,681 Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 19:54 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 3,000 | $6.12 | $18,360.00 |
DisclosureSEC source: 0001628280-24-000820 · wk-form4_1704743687.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,681 Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 18:37 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 500 | $5.83 | $2,915.00 |
DisclosureSEC source: 0001628280-24-000388 · wk-form4_1704393413.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,681 Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 16:48 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 2,500 | $4.92 | $12,300.00 |
DisclosureSEC source: 0001628280-23-042662 · wk-form4_1703609285.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,181 Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 19:31 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 2,100 | $4.82 | $10,122.00 |
DisclosureSEC source: 0001628280-23-042467 · wk-form4_1703187064.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,681 Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 14:48 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 5,000 | $4.75 | $23,750.00 |
DisclosureSEC source: 0001628280-23-042096 · wk-form4_1703083724.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,581 Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 17:00 UTC |
TOBIN SCOTT RDirector · 10% owner
|
GrantOption to purchase Common Stock · Derivative | 28,600 | $5.51 Strike: $5.51 | $157,586.00 |
DisclosureSEC source: 0001628280-23-037251 · wk-form4_1699376392.xml · derivative · entry 1 TOBIN SCOTT R · CIK 0001199926 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,600 Underlying: Common Stock · 28,600 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 16:59 UTC |
ACKERMAN JOELDirector
|
GrantOption to purchase Common Stock · Derivative | 35,750 | $5.51 Strike: $5.51 | $196,982.50 |
DisclosureSEC source: 0001628280-23-037250 · wk-form4_1699376342.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,750 Underlying: Common Stock · 35,750 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 16:58 UTC |
Mendelson Daniel NewmanDirector
|
GrantOption to purchase Common Stock · Derivative | 26,220 | $5.51 Strike: $5.51 | $144,472.20 |
DisclosureSEC source: 0001628280-23-037249 · wk-form4_1699376309.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,220 Underlying: Common Stock · 26,220 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 16:57 UTC |
SIDRANSKY DAVIDDirector
|
GrantOption to purchase Common Stock · Derivative | 15,495 | $5.51 Strike: $5.51 | $85,377.45 |
DisclosureSEC source: 0001628280-23-037248 · wk-form4_1699376259.xml · derivative · entry 1 SIDRANSKY DAVID · CIK 0001277161 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,495 Underlying: Common Stock · 15,495 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 16:57 UTC |
Breitfeld Philip P.Director
|
GrantOption to purchase Common Stock · Derivative | 15,495 | $5.51 Strike: $5.51 | $85,377.45 |
DisclosureSEC source: 0001628280-23-037245 · wk-form4_1699376211.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,495 Underlying: Common Stock · 15,495 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| November 03, 2023 Filed Jan 30, 2026 17:15 UTC |
Brainin Robert LawrenceDirector
|
GrantOption to purchase Common Stock · Derivative | 19,070 | $5.51 Strike: $5.51 | $105,075.70 |
DisclosureSEC source: 0001628280-26-004342 · wk-form4_1769793351.xml · derivative · entry 3 Brainin Robert Lawrence · CIK 0002088015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,133 Underlying: Common Stock · 19,070 shares Expires 2033-11-03 F3 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| October 17, 2023 Filed Jan 5, 2024 20:52 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionOption to purchase Common Stock · Derivative | 14,552 | $2.10 Strike: $2.10 | $30,559.20 |
DisclosureSEC source: 0001628280-24-000639 · wk-form4_1704487909.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,552 shares Expires 2023-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on July 19, 2016. Read SEC document |
| October 17, 2023 Filed Jan 5, 2024 20:52 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionOption to purchase Common Stock · Derivative | 100,000 | $2.10 Strike: $2.10 | $210,000.00 |
DisclosureSEC source: 0001628280-24-000639 · wk-form4_1704487909.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2023-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 84,600 options were immediately exercisable upon grant on July 19, 2016 with the remaining options vesting on August 5, 2016 and November 5, 2016. Read SEC document |
| October 17, 2023 Filed Jan 5, 2024 20:52 UTC |
ACKERMAN JOELDirector
|
Exercise / conversionCommon Stock | 114,552 | $2.10 | $240,559.20 |
DisclosureSEC source: 0001628280-24-000639 · wk-form4_1704487909.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 856,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2023 Filed Oct 13, 2023 16:48 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 5,000 | $6.40 | $32,000.00 |
DisclosureSEC source: 0001628280-23-034348 · wk-form4_1697215682.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,081 Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 13:45 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 1,100 | $6.41 | $7,051.00 |
DisclosureSEC source: 0001628280-23-034231 · wk-form4_1697031899.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,081 Read SEC document |
| October 09, 2023 Filed Apr 1, 2024 19:18 UTC |
Davis BradyPresident
|
GrantOption to purchase Common Stock · Derivative | 68,000 | $6.50 Strike: $6.50 | $442,000.00 |
DisclosureSEC source: 0001628280-24-013993 · wk-form4_1711999092.xml · derivative · entry 3 Davis Brady · CIK 0002002615 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,500 Underlying: Common Stock · 68,000 shares Expires 2033-10-09 F3 · derivative.exercise_date: The options vest over a four year period starting from the one year anniversary of the achievement of specific performance criteria and are exercisable over a ten year period. Read SEC document |
| October 09, 2023 Filed Apr 1, 2024 19:18 UTC |
Davis BradyPresident
|
GrantOption to purchase Common Stock · Derivative | 7,500 | $6.50 Strike: $6.50 | $48,750.00 |
DisclosureSEC source: 0001628280-24-013993 · wk-form4_1711999092.xml · derivative · entry 2 Davis Brady · CIK 0002002615 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,500 Underlying: Common Stock · 7,500 shares Expires 2033-10-09 F2 · derivative.exercise_date: The options vest fully (100%) on the one year anniversary of the date of grant and are exercisable over a ten year period, with vesting to occur on October 9, 2024. Read SEC document |
| October 09, 2023 Filed Apr 1, 2024 19:18 UTC |
Davis BradyPresident
|
GrantOption to purchase Common Stock · Derivative | 135,000 | $6.50 Strike: $6.50 | $877,500.00 |
DisclosureSEC source: 0001628280-24-013993 · wk-form4_1711999092.xml · derivative · entry 1 Davis Brady · CIK 0002002615 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-10-09 F1 · derivative.exercise_date: The options vest over a four year period and are exercisable over a ten year period, with vesting to occur on October 9, 2024, October 9, 2025, October 9, 2026 and October 9, 2027, respectively. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 14:02 UTC |
Mendelson Daniel NewmanDirector
|
PurchaseCommon Stock | 1,530 | $6.48 | $9,914.40 |
DisclosureSEC source: 0001628280-23-034119 · wk-form4_1696946525.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,981 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.